Identification of conserved hydrophobic c-terminal residues of the human papillomavirus type 1 E1:E4 protein necessary for E4 oligomerisation in vivo

Virology

Volumn 240, Issue 2, 1998, Pages 221-231

  Ashmole, Ian ^a   Gallimore, Phillip H ^a   Roberts, Sally ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DNA BINDING PROTEIN; HYBRID PROTEIN; ISOLEUCINE; PHENYLALANINE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; HYDROPHOBICITY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; TRANSACTIVATION; WART VIRUS;

EID: 0032518487     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8909     Document Type: Article

References (35)

1. Baker C. C., Howley P. M. Differential promoter utilization by bovine papillomavirus in transformed cells and productively-infected wart tissue. EMBO. J. 6:1987;1027-1037.
2. Breitburd F., Croissant O., Orth G. Expression of human papillomavirus type 1 E4 gene products in warts. Papillomaviruses: Cancer Cells. 1987;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 115-122.
3. ∧. Virology. 214:1995;259-263.
4. Chow L. T., Nasseri M., Wolinsky S. M., Broker T. R. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61:1987a;2581-2588.
5. Chow L. T., Reilly S. S., Broker T. R., Taichman L. B. Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J. Virol. 61:1987b;1913-1918.
6. Croissant O., Breitburd F., Orth G. Specificity of cytopathic effect of cutaneous human papillomaviruses. Clin. Dermatol. 3:1985;43-55.
7. Crum C. P., Barber S., Symbula M., Snyder K., Saleh A. M., Roche J. K. Coexpression of the human papillomavirus type 16 E4 and L1 open reading frames in early cervical neoplasia. Virology. 178:1990;238-246.
8. Doorbar J., Campbell D., Grand R. J. A., Gallimore P. H. Identification of the human papilloma virus-1a E4 gene products. EMBO J. 5:1986;355-362.
9. Doorbar J., Coneron I., Gallimore P. H. Sequence divergence yet conserved physical characteristics among the E4 proteins of cutaneous human papillomaviruses. Virology. 172:1989;51-62.
10. Doorbar J., Ely S., Sterling J., McClean C., Crawford L. Specific interaction between HPV 16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature. 352:1991;824-827.
11. Doorbar J., Evans H. S., Coneron I., Crawford L. V., Gallimore P. H. Analysis of HPV-1 E4 gene expression using epitope-defined antibodies. EMBO J. 7:1988;825-833.
12. Doorbar J., Medcalf E., Napthine S. Analysis of HPV 1 E4 complexes and their association with keratins in vivo. Virology. 218:1996;114-126.
13. Doorbar J., Myers G. The E4 protein. Myers G., Halpern A., Baker C., McBride A., Wheeler C., Doorbar J. Human Papillomaviruses: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. 1996;III-58-III-80.
14. Geourjon C., Deleage G. SOPM: A self-optimised prediction method for protein secondary structure prediction. Protein Eng. 7:1994;157-184.
15. Golemis E. A., Gyuris J., Brent R. Two hybrid systems/interaction traps. Ausubel F. M., Brent R., Kingston R., Moore D., Seidman J., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1994;13.14.1-13.14.17 Wiley, New York.
16. Grand R. J. A., Doorbar J., Smith K. J., Coneron I., Gallimore P. H. Phosphorylation of the human papillomavirus type 1 E4 proteinsin vivoin vitro. Virology. 170:1989;201-213.
17. Gyuris J., Golemis E., Chertkov H., Brent R. Cdi 1, a human G1 and S phase protein phosphatase that associates with Cdk 2. Cell. 75:1993;791-803.
18. Higgins G. D., Uzelin D. M., Phillips G. E., McCoy P., Marin R., Burrell C. J. Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasias: Evidence for promoter usage with the E7 open reading frame during epithelial differentiation. J. Gen. Virol. 73:1992;2047-2057.
19. Jareborg N., Burnett S. Immunofluorescent detection of bovine papillomavirus E4 antigen in the cytoplasm of cells permissivein vitro. J. Gen. Virol. 72:1991;2269-2274.
20. Miller J. H. Experiments in Molecular Genetics. 1972;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 352-355.
21. ∧. Virology. 159:1987;433-439.
22. Neary K., Horwitz B. H., DiMaio D. Mutational analysis of open reading frame E4 of bovine papillomavirus type 1. J. Virol. 61:1987;1248-1252.
23. Palermo-Dilts D. A., Broker T. R., Chow L. T. Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts. J. Virol. 64:1990;3144-3149.
24. ∧. Virology. 206:1995;679-685.
25. Roberts S., Ashmole I., Johnson G. D., Kreider J. W., Gallimore P. H. Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Virology. 197:1993;176-187.
26. Roberts S., Ashmole I., Gibson L. J., Rookes S. M., Barton G. J., Gallimore P. H. Mutational analysis of human papillomavirus E4 proteins: Identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J. Virol. 68:1994a;6432-6445.
27. ∧. J. Virol. 71:1997;3554-3562.
28. Roberts S., Ashmole I., Sheehan T. M. T., Davies A. H., Gallimore P. H. Human papillomavirus type 1 E4 protein is a zinc-binding protein. Virology. 202:1994b;865-874.
29. Rogel-Gaillard C., Pehau-Arnaudet G., Breitburd F., Orth G. Cytopathic effect in human papillomavirus type 1-induced inclusion warts:In vitro. J. Invest. Dermatol. 101:1993;843-851.
30. Schiestl R. H., Gietz R. D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16:1989;339-346.
31. Stamps A. C., Campo M. S. Mapping of two novel transcripts of bovine papillomavirus type 4. J. Gen. Virol. 69:1988;3033-3045.
32. Sterling J. C., Skepper J. N., Stanley M. A. Immunoelectron microscopical localization of human papillomavirus type 16 L1 and E4 proteins in cervical keratinocytes culturedin vivo. J. Invest. Dermatol. 100:1993;154-158.
33. Stoler M. H., Wolinsky S. M., Whitbeck A., Broker T. R., Chow L. T. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed byin situ. Virology. 172:1989;331-340.
34. Tomita Y., Fuse A., Sekine H., Shirasawa H., Simizu B., Sugimoto M., Funahashi S. Human papillomavirus type 6 and 11 E4 gene products in condyloma acuminata. J. Gen. Virol. 72:1991;731-734.
35. Zhu Q-L., Smith T. F., Lefkowitz E. J., Chow L. T., Broker T. R. Nucleic Acid and Protein Sequence Alignments of Human and Animal Papillomaviruses Constrained by Functional Sites. 1994;Univ. of Alabama at Birmingham Press, Birmingham.